US Stock MarketDetailed Quotes

SLRN Acelyrin

Watchlist
  • 4.200
  • -0.010-0.24%
Close Jun 18 16:00 ET
  • 4.250
  • +0.050+1.19%
Post 19:11 ET
415.91MMarket Cap-1729P/E (TTM)

About Acelyrin Company

ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.

Company Profile

SymbolSLRN
Company NameAcelyrin
Listing DateMay 5, 2023
Issue Price18.00
Founded2020
CEOMs. Mina Kim
MarketNASDAQ
Employees130
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4149 Liberty Canyon Road
CityAgoura Hills
ProvinceCalifornia
CountryUnited States of America
Zip Code91301
Phone1-805-730-0360
Websitehttp://www.acelyrin.com

Company Executives

  • Name
  • Position
  • Salary
  • Mina Kim
  • Director and Chief Executive Officer
  • --
  • Sanam Pangali
  • Chief Legal Officer and Head of People
  • --
  • Ron Oyston
  • Chief People Officer
  • 9.95M
  • Shephard Mpofu, M.D.
  • Chief Medical Officer
  • --
  • Melanie Gloria
  • Chief Operating Officer
  • 11.48M
  • Gil M. Labrucherie
  • Chief Business Officer, Chief Financial Officer and Principal Accounting Officer
  • --
  • Bruce C. Cozadd
  • Chairman of the Board
  • 390.49K
  • Dawn A. Svoronos
  • Independent Director
  • 376.67K
  • Dr. Daniel Becker, M.D.,PhD
  • Independent Director
  • 351.09K
  • Dr. Alan B. Colowick, M.D.,M.P.H.
  • Independent Director
  • --
  • Patrick C. Machado, J.D.
  • Independent Director
  • 402.20K
  • Dr. Beth C. Seidenberg,M.D.
  • Independent Director
  • 349.51K
  • Lynn A. Tetrault, J.D.
  • Independent Director
  • 482.26K
  • Henry O. Gosebruch
  • Independent Director
  • 1.02M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg